The highly accurate Captia™ SARS CoV-2 antibody testing is available utilizing ELISA. This test has a sensitivity value of 97.9% to 100% and specificity values of 97.7% to 100%.
COVID-19 Patient Testing
COVID-19 Testing Patient Information
Use the buttons at right to schedule a COVID-19 test using our convenient online scheduling tool and to download our COVID-19 Test Request Form that will need to be completed and provided at the time of your COVID-19 test. You must complete both steps.
COVID-19 PCR Test Information
A COVID-19 PCR or molecular test will let you know if you have an active infection of COVID-19. This test is positive when you are contagious and can spread it to others. You may or may not have any symptoms. A negative test indicates that you either were never infected, or that you may have been infected but your body has fought off the infection and you are no longer contagious.
PCR stands for Polymerase Chain Reaction. It is also known as a NAAT test (Nucleic Acid Amplification Test). This test detects one or more RNA gene targets specific to the virus. The RNA is extracted from the virus which is used to make millions to billions of copies of the DNA. Amplifying the sample allows it to be diagnosed specifically. This process takes a minimum of 6 hours to complete.
Immco has a scheduling tool so that we can get your test results to you as quickly as possible.
COVID-19 Antibody Test Information
An antibody test looks for the presence of antibodies, which are specific proteins made in response to infections. Antibodies are typically detected in the blood of people who are tested after infection; they show an immune response to the infection. Antibody test results are especially important for detecting previous infections in people who had few or no symptoms.
CDC scientists are conducting studies to determine how much protection (immunity) antibodies might provide against getting infected again. Based on what we know from similar viruses; some reinfections are expected. Confirmed and suspected cases of reinfection of the virus that causes COVID-19 have been reported, but remain rare.
- In general, a positive antibody test is presumed to mean a person has been infected with SARS-CoV-2, the virus that causes COVID-19, at some point in the past. It does not mean they are currently infected.
- Antibodies usually start developing within 1 to 3 weeks after infection.
- We don’t have enough information yet to say how protected someone might be from being infected again if they have antibodies to the virus.
- Confirmed and suspected cases of reinfection with the virus have been reported, but remain rare.
- People who receive positive results on an antibody test but don’t have symptoms of COVID-19 and have not been around someone who may have COVID-19 are not likely to have a current infection. They can continue with normal activities, including work, but still take steps to protect themselves and others.
- People who receive positive results on an antibody test and who are currently or recently sick or have been around someone with COVID-19 should follow CDC recommendations on caring for themselves and protecting others, and when they can be around other people again.
Insurance Coverage for COVID-19 Testing
Insurance will cover testing for individuals who have been exposed to someone infected or those that are showing symptoms. Typically, testing for travel purposes would not be covered. To be sure, contact your insurance carrier, Medicare, or Medicaid.
The cost of the test is $99.
SARS CoV-2 Information
SARS-CoV-2 stands for severe acute respiratory syndrome coronavirus 2. SARS-CoV-2 is the strain of coronavirus that causes the COVID-19 disease.
The 2019, the Chinese government initially called the outbreak of lower respiratory tract disease novel coronavirus pneumonia (NCP). It was then referred to as 2019-nCoV. The disease name was subsequently recommended as COVID-19 by the World Health Organization. Meanwhile, it was renamed SARS-CoV-2 by the International Committee on Taxonomy of Viruses.
All of these names refer to the same disease.